Hereditary Sensory and Autonomic Neuropathy Type Ie
|
0.720 |
GeneticVariation
|
disease |
BEFREE |
We previously discovered DNMT1 mutations cause hereditary sensory and autonomic neuropathy type 1 with dementia and hearing loss (HSAN1E; OMIM 614116).
|
25033457 |
2014 |
Hereditary Sensory and Autonomic Neuropathy Type Ie
|
0.720 |
Biomarker
|
disease |
GENOMICS_ENGLAND |
Polysomnographic and neurometabolic features may mark preclinical autosomal dominant cerebellar ataxia, deafness, and narcolepsy due to a mutation in the DNA (cytosine-5-)-methyltransferase gene, DNMT1.
|
24709307 |
2014 |
Hereditary Sensory and Autonomic Neuropathy Type Ie
|
0.720 |
GermlineCausalMutation
|
disease |
ORPHANET |
DNMT1 mutation hot spot causes varied phenotypes of HSAN1 with dementia and hearing loss.
|
23365052 |
2013 |
Hereditary Sensory and Autonomic Neuropathy Type Ie
|
0.720 |
Biomarker
|
disease |
GENOMICS_ENGLAND |
A novel de novo exon 21 DNMT1 mutation causes cerebellar ataxia, deafness, and narcolepsy in a Brazilian patient.
|
23904686 |
2013 |
Hereditary Sensory and Autonomic Neuropathy Type Ie
|
0.720 |
Biomarker
|
disease |
GENOMICS_ENGLAND |
DNMT1 mutation hot spot causes varied phenotypes of HSAN1 with dementia and hearing loss.
|
23365052 |
2013 |
Hereditary Sensory and Autonomic Neuropathy Type Ie
|
0.720 |
Biomarker
|
disease |
GENOMICS_ENGLAND |
Mutations in DNMT1 cause hereditary sensory neuropathy with dementia and hearing loss.
|
21532572 |
2011 |
Hereditary Sensory and Autonomic Neuropathy Type Ie
|
0.720 |
GermlineCausalMutation
|
disease |
ORPHANET |
Mutations in DNMT1 cause hereditary sensory neuropathy with dementia and hearing loss.
|
21532572 |
2011 |
Hereditary Sensory and Autonomic Neuropathy Type Ie
|
0.720 |
GeneticVariation
|
disease |
UNIPROT |
Mutations in DNMT1 cause hereditary sensory neuropathy with dementia and hearing loss.
|
21532572 |
2011 |
Hereditary Sensory and Autonomic Neuropathy Type Ie
|
0.720 |
Biomarker
|
disease |
GENOMICS_ENGLAND |
Sex-specific exons control DNA methyltransferase in mammalian germ cells.
|
9449671 |
1998 |
Hereditary Sensory and Autonomic Neuropathy Type Ie
|
0.720 |
Biomarker
|
disease |
GENOMICS_ENGLAND |
|
|
|
Hereditary Sensory and Autonomic Neuropathy Type Ie
|
0.720 |
GeneticVariation
|
disease |
CLINVAR |
|
|
|
Hereditary Sensory and Autonomic Neuropathy Type Ie
|
0.720 |
Biomarker
|
disease |
CTD_human |
|
|
|
Hereditary Sensory and Autonomic Neuropathy Type Ie
|
0.720 |
CausalMutation
|
disease |
CLINVAR |
|
|
|
Colonic Neoplasms
|
0.520 |
Biomarker
|
group |
BEFREE |
Levels of DNA methyltransferase 1 (DNMT1) and protein arginine methyltransferase 6 (PRMT6) were increased in colon tumors from Ppara<sup>ΔIE</sup> mice, compared with colon tumors from control mice.
|
31154022 |
2019 |
Colonic Neoplasms
|
0.520 |
AlteredExpression
|
group |
BEFREE |
The DNMT1 protein was overexpressed in colon tumours from patients compared to non-malignant mucosa from the same patients (P = 0.02).
|
30663502 |
2018 |
Colonic Neoplasms
|
0.520 |
Biomarker
|
group |
CTD_human |
Further, 5-azacytidine potentiated cisplatin induced antitumor activity by involving decreased expression of pAKT, DNMT1 and an increased expression of p38 in colon tumors.
|
19723570 |
2009 |
Colonic Neoplasms
|
0.520 |
Therapeutic
|
group |
RGD |
Further, 5-azacytidine potentiated cisplatin induced antitumor activity by involving decreased expression of pAKT, DNMT1 and an increased expression of p38 in colon tumors.
|
19723570 |
2009 |
hearing impairment
|
0.510 |
Biomarker
|
phenotype |
BEFREE |
Studies reporting sleep as a secondary aim generally report poorer sleep in HI participants.
|
31626556 |
2019 |
hearing impairment
|
0.510 |
Biomarker
|
phenotype |
CTD_human |
Mutations in DNMT1 cause hereditary sensory neuropathy with dementia and hearing loss.
|
21532572 |
2011 |
hearing impairment
|
0.510 |
Biomarker
|
phenotype |
GENOMICS_ENGLAND |
Sex-specific exons control DNA methyltransferase in mammalian germ cells.
|
9449671 |
1998 |
Dementia
|
0.450 |
GeneticVariation
|
disease |
BEFREE |
As mutations in DNMT1 cause a rare dominant form of narcolepsy in association with deafness, cerebellar ataxia and dementia, we questioned whether the association with P2RY11 in sporadic narcolepsy could be secondary to linkage disequilibrium with DNMT1.
|
25669430 |
2015 |
Dementia
|
0.450 |
GeneticVariation
|
disease |
BEFREE |
We report on the extensive phenotypic characterization of five Italian patients from four unrelated families carrying dominant heterozygous DNMT1 mutations linked to two distinct autosomal dominant diseases: hereditary sensory and autonomic neuropathy with dementia and hearing loss type IE (HSAN IE) and autosomal dominant cerebellar ataxia, deafness and narcolepsy (ADCA-DN).
|
24727570 |
2014 |
Dementia
|
0.450 |
GeneticVariation
|
disease |
BEFREE |
Mutations in DNMT1 were specific to 2 HSAN1E kindreds with dementia and hearing loss (no narcolepsy).
|
23365052 |
2013 |
Dementia
|
0.450 |
GeneticVariation
|
disease |
BEFREE |
And mutations in DNMT1 can induce one form of neurodegenerative diseases with dementia and sensorineural hearing loss.
|
23771421 |
2013 |
Dementia
|
0.450 |
GeneticVariation
|
disease |
BEFREE |
Here we show that mutations in DNMT1 cause both central and peripheral neurodegeneration in one form of hereditary sensory and autonomic neuropathy with dementia and hearing loss.
|
21532572 |
2011 |